Innovation trifft Strategie: Bei Group IT gestaltest du die IT-Zukunft der Helvetia Gruppe aktiv mit. Hier vereinen sich Expertise und Vision, um gemeinsam mit den Ländermärkten die IT-Strategie kontinuierlich weiterzuentwickeln und eine klare Richtung für die
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Salary Range:CHF122,500.00 - CHF227,500.00 BandLevel 5 Job Description SummaryAs a Delivery Lead for Lab Automation & Logistics in Data & Digital (D&D), you will drive the delivery and adoption of cutting-edge automation, orchestration, and AI-enabled solutions
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Position Overview We are seeking an experienced Infrastructure Solutions Architect to join our Infrastructure & Operations organization. In this strategic role, you will design, govern, and drive the implementation of scalable, secure, and resilient enterprise infrastructure
The Opportunity: Avantor is looking for a dedicated Applications Support Specialist to join our team in Basel. This role encompasses the development and maintenance of custom applications provided as a service to internal stakeholders, alongside the
Salary Range:CHF115,500.00 - CHF214,500.00 BandLevel 5 Job Description Summary#LI-Hybrid Location: Basel, Switzerland Join Novartis Internal Audit at the forefront of technology innovation, where you will help safeguard and shape the future of data, Artificial Intelligence, cybersecurity
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description At Syngenta Crop Protection, were pioneering solutions that safeguard global food security while championing sustainable agriculture. As a world market leader headquartered in Switzerland, we empower farmers with innovative crop protection technologies that defend against
Introduction Move the world with us! Wake up each day to be part of a global movement.A movement tomake an impact. A movement togo for it!A movement toprovide best-in class solutions. A movement to beempowered. A
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
IT Security Engineer sciCORE is the center of competence for scientific computing at the University of Basel, the oldest university in Switzerland and consistently ranked among the best universities in the world. The University is highly research-oriented,
Your position Act as the primary security subject matter expert for sciCORE infrastructures and research-support services Contribute proactively to the secure architecture and operation of sciCORE services, including security-related tools, HPC systems, web applications, trusted research environments (sciCORE+),
About Us Ikerian AG (formerly RetinAI Medical) is a fast-growing medical device software company headquartered in Bern, Switzerland. Our mission is to enable the right decisions sooner in healthcare, through transformative AI & data management solutions